Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Canagliflozin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Sep 2017 Results (n=24) presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 07 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2017.
- 07 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.